Literature DB >> 2942327

Plasma levels of atrial natriuretic peptide in man in primary aldosteronism, in Gordon's syndrome and in Bartter's syndrome.

T J Tunny, B A Higgins, R D Gordon.   

Abstract

Plasma levels of ANP were measured in normal subjects and in three conditions associated with disturbed volume homeostasis. Levels of ANP were appropriately raised in seven patients with primary aldosteronism, and fell to normal following removal of an aldosterone-producing adenoma in six and dexamethasone treatment in one patient with glucocorticoid-suppressible hyperaldosteronism. The level of ANP in one patient with Gordon's syndrome (a condition associated with plasma volume expansion) was lower than in the patients with primary aldosteronism, both before and after saline infusion. This is consistent with reduced ANP responsiveness in this condition. responsiveness in this condition. Levels of ANP were inappropriately elevated in three patients with Bartter's syndrome (a condition with plasma volume contraction) and rose further during saline infusion. This is consistent with primary hypersecretion of ANP.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2942327     DOI: 10.1111/j.1440-1681.1986.tb00360.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  11 in total

1.  Normal renal sensitivity to atrial natriuretic peptide in Gordon's syndrome.

Authors:  M Välimäki; R Pelkonen; I Tikkanen; F Fyhriquist
Journal:  Pediatr Nephrol       Date:  1992-01       Impact factor: 3.714

2.  Raised plasma levels of atrial natriuretic peptides in Addison's disease.

Authors:  F P Cappuccio; N D Markandu; M G Buckley; A L Sugden; G A Sagnella; G A MacGregor
Journal:  J Endocrinol Invest       Date:  1989-03       Impact factor: 4.256

Review 3.  Effects of exercise on atrial natriuretic factor. Release mechanisms and implications for fluid homeostasis.

Authors:  B J Freund; C E Wade; J R Claybaugh
Journal:  Sports Med       Date:  1988-12       Impact factor: 11.136

Review 4.  [Atrial natriuretic peptide and its significance for arterial hypertension].

Authors:  G Wambach; M Stimpel; G Bönner
Journal:  Klin Wochenschr       Date:  1989-11-03

5.  "Chloride-shunt" syndrome: an overlooked cause of renal hypercalciuria.

Authors:  J Rodríguez-Soriano; A Vallo; M J Domínguez
Journal:  Pediatr Nephrol       Date:  1989-04       Impact factor: 3.714

6.  Lack of aldosterone inhibition by atrial natriuretic factor in primary aldosteronism: in vitro studies.

Authors:  S Rocco; G Opocher; D D'Agostino; L Leone; F Mantero
Journal:  J Endocrinol Invest       Date:  1989-01       Impact factor: 4.256

7.  Atrial natriuretic factor significantly contributes to the mineralocorticoid escape phenomenon. Evidence for a guanylate cyclase-mediated pathway.

Authors:  N Yokota; B G Bruneau; M L Kuroski de Bold; A J de Bold
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

8.  Elevation of plasma atrial natriuretic peptide occurs during adrenaline infusion in hypertensive but not normotensive subjects.

Authors:  T J Tunny; R D Gordon; A W Bachmann; S A Klemm
Journal:  Clin Auton Res       Date:  1992-10       Impact factor: 4.435

Review 9.  Renal tubular hyperkalaemia in childhood.

Authors:  J Rodríguez-Soriano; A Vallo
Journal:  Pediatr Nephrol       Date:  1988-10       Impact factor: 3.714

10.  The syndrome of hypertension and hyperkalaemia with normal glomerular function (Gordon's syndrome). A pathophysiological study.

Authors:  B Semmekrot; L Monnens; B G Theelen; W Rascher; F Gabreëls; J Willems
Journal:  Pediatr Nephrol       Date:  1987-07       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.